I believe SANA is about to see a strong rebound after presenting their 8-week interim analysis on Monday. Given the positive results so far, I expect ...
Read
More
I believe SANA is about to see a strong rebound after presenting their 8-week interim analysis on Monday. Given the positive results so far, I expect the stock to spike again like it did previously, especially with their potential to revolutionize diabetes treatment on the horizon.
I believe $SANA is fundamentally undervalued considering its revolutionary immune-evasive tech. With potential catalysts on the horizon and a market c...
Read
More
I believe $SANA is fundamentally undervalued considering its revolutionary immune-evasive tech. With potential catalysts on the horizon and a market cap that's a fraction of the market potential, I see a solid opportunity here. I'm loading up on OTM calls to capitalize on any upswing, targeting $10 soon.
I'm loading up on SANA shares because I believe the advancements in their Hypo immune technology could revolutionize the treatment of diseases like ty...
Read
More
I'm loading up on SANA shares because I believe the advancements in their Hypo immune technology could revolutionize the treatment of diseases like type 1 diabetes. With promising early trial results and the CEO's strong track record, I see significant upside potential as market awareness increases.
After observing SANA's significant parabolic move up over 220%, I believe there's a critical opportunity to capitalize on its decline by taking out pu...
Read
More
After observing SANA's significant parabolic move up over 220%, I believe there's a critical opportunity to capitalize on its decline by taking out puts. Given the volatility, it's a perfect play to ride the downward correction.
I just saw the fantastic news about SANA and their groundbreaking results in treating Type 1 Diabetes. With the positive clinical results and the high...
Read
More
I just saw the fantastic news about SANA and their groundbreaking results in treating Type 1 Diabetes. With the positive clinical results and the high pre-market volume, I think there’s a good chance for a breakout today, and I’m looking to capitalize on that.
I'm all in on SANA after their promising clinical results for type 1 diabetes. The potential upside is massive, especially with the company's strong c...
Read
More
I'm all in on SANA after their promising clinical results for type 1 diabetes. The potential upside is massive, especially with the company's strong cash position and the recent price movement. I believe we could see this stock push over $10 very soon and it’s definitely undervalued right now.